Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Nov;26(2):515–519. doi: 10.1128/iai.26.2.515-519.1979

Role of interferon in mice in protection against influenza A virus by bacterial ribosomes together with membranal glycoproteins of Klebsiella pneumoniae as adjuvant.

D Robert, J P Quillon, B Ivanoff, Y Beaudry, R Fontanges, G Normier, A M Pinel, L D D'hinterland
PMCID: PMC414646  PMID: 94908

Abstract

Nonspecific protection against infectious aerosols of influenza A virus was obtained in Swiss mice after vaccination by aerosols of bacterial ribosomes together with membranal glycoproteins extracted from Klebsiella pneumoniae as the adjuvant. It was shown that repeated stimulant aerosols were necessary to obtain this protection. Routine estimation of serum interferon levels after administration of the association of ribosomes plus membranal glycoproteins to the animals by aerosol or intravenous route showed that there was no correlation between protection and the presence of serum interferon. It was shown that the serum interferon-inducer activity was due to ribosomes. No induction of serum interferon was obtained with membranal glycoproteins used separately. Local liberation of interferon in the mucous membrane of the upper respiratory tract was not investigated.

Full text

PDF
515

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andron LA I. I., Eigelsbach H. T. Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis. Infect Immun. 1975 Jul;12(1):137–142. doi: 10.1128/iai.12.1.137-142.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BURTON K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956 Feb;62(2):315–323. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baron S., Levy H. B. Interferon. Annu Rev Microbiol. 1966;20:291–318. doi: 10.1146/annurev.mi.20.100166.001451. [DOI] [PubMed] [Google Scholar]
  4. Baron S. The biological significance of the interferon system. Arch Intern Med. 1970 Jul;126(1):84–93. [PubMed] [Google Scholar]
  5. Cofré G., Calderón I., Mora G. C. Immunogenic capacity of ribosomes of Salmonella typhi interfered with a flagellin-like material contaminant. Infect Immun. 1978 Apr;20(1):161–166. doi: 10.1128/iai.20.1.161-166.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Coppel S., Youmans G. P. Specificity of acquired resistance produced by immunization with mycobacterial cells and mycobacterial fractions. J Bacteriol. 1969 Jan;97(1):114–120. doi: 10.1128/jb.97.1.114-120.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dahl H., Degré M. Preventive effect of a nonviral interferon inducer, a bacterial vaccine, on experimental influenza in mice. Acta Pathol Microbiol Scand B Microbiol Immunol. 1972;80(3):467–474. doi: 10.1111/j.1699-0463.1972.tb00062.x. [DOI] [PubMed] [Google Scholar]
  8. De Clercq E., Merigan T. C. An active interferon inducer obtained from Hemophilus influenzae type B. J Immunol. 1969 Nov;103(5):899–906. [PubMed] [Google Scholar]
  9. De Clercq E., Merigan T. C. Induction of interferon by nonviral agents. Arch Intern Med. 1970 Jul;126(1):94–108. doi: 10.1001/archinte.126.1.94. [DOI] [PubMed] [Google Scholar]
  10. Degre M., Dahl H. Production of an interferon-like agent following inoculation with bacterial vaccine. Proc Soc Exp Biol Med. 1971 May;137(1):233–236. doi: 10.3181/00379727-137-35551. [DOI] [PubMed] [Google Scholar]
  11. Degré M., Dahl H. Enhanced effect of repeated administration of bacterial vaccine against viral respiratory infection. Infect Immun. 1973 May;7(5):771–776. doi: 10.1128/iai.7.5.771-776.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Eisenstein T. K. Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella. Infect Immun. 1975 Aug;12(2):364–377. doi: 10.1128/iai.12.2.364-377.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Elson L. A., Morgan W. T. A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J. 1933;27(6):1824–1828. doi: 10.1042/bj0271824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Falcoff R., Falcoff E. T. Induction de la synthèse d'interféron par des RNA bicaténaires. I. Application à l'étude du cycle de multiplication du virus Mengo. Biochim Biophys Acta. 1969 Jun 17;182(2):501–510. [PubMed] [Google Scholar]
  15. Field A. K., Tytell A. A., Lampson G. P., Hilleman M. R. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci U S A. 1967 Sep;58(3):1004–1010. doi: 10.1073/pnas.58.3.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Finkelstein M. S., Bausek G. H., Merigan T. C. Interferon inducers in vitro: difference in sensitivity to inhbitiros of RNA and protein synthesis. Science. 1968 Aug 2;161(3840):465–468. doi: 10.1126/science.161.3840.465. [DOI] [PubMed] [Google Scholar]
  17. Gresser I., Tovey M. G., Maury C., Bandu M. T. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J Exp Med. 1976 Nov 2;144(5):1316–1323. doi: 10.1084/jem.144.5.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ho M., Armstrong J. A. Interferon. Annu Rev Microbiol. 1975;29:131–161. doi: 10.1146/annurev.mi.29.100175.001023. [DOI] [PubMed] [Google Scholar]
  19. Hoops P., Prather N. E., Berry J., Ravel J. M. Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium. Infect Immun. 1976 Apr;13(4):1184–1192. doi: 10.1128/iai.13.4.1184-1192.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Janda J., Work E. A colorimetric estimation of lipopolysaccharides. FEBS Lett. 1971 Sep 1;16(4):343–345. doi: 10.1016/0014-5793(71)80386-1. [DOI] [PubMed] [Google Scholar]
  21. Jensen R., Gregory B., Naylor J., Actor P. Isolation of protective somatic antigen from Vibrio cholerae (Ogawa) ribosomal preparations. Infect Immun. 1972 Aug;6(2):156–161. doi: 10.1128/iai.6.2.156-161.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Johnson W. Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium. Infect Immun. 1973 Sep;8(3):395–400. doi: 10.1128/iai.8.3.395-400.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kato N., Nakashima I., Ota M. Interferon production in mice by the capsular polysaccharide of Klebsiella pneumoniae. Infect Immun. 1975 Jul;12(1):1–6. doi: 10.1128/iai.12.1.1-6.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kirchner H., Hirt H. M., Becker H., Munk K. Production of an antiviral factor by murine spleen cells after treatment with Corynebacterium parvum. Cell Immunol. 1977 Jun 1;31(1):172–176. doi: 10.1016/0008-8749(77)90016-8. [DOI] [PubMed] [Google Scholar]
  25. Kleinschmidt W. J., Streightoff F. Inhibition of influenza virus and interferon response intranasally with statolon. Infect Immun. 1971 Dec;4(6):738–741. doi: 10.1128/iai.4.6.738-741.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  27. Lin J. H., Berry L. J. The use of strain LT2-Ml in identifying the protective antigens in a Salmonella typhimurium-derived ribosomal vaccine. J Reticuloendothel Soc. 1978 Feb;23(2):135–143. [PubMed] [Google Scholar]
  28. Lindh H. F., Lindsay H. L., Mayberry B. R., Forbes M. Polyinosinic-cytidylic acid complex (poly I:C) and viral infections in mice. Proc Soc Exp Biol Med. 1969 Oct;132(1):83–87. doi: 10.3181/00379727-132-34153. [DOI] [PubMed] [Google Scholar]
  29. Lodmell D. L., Ewalt L. C. Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine. Infect Immun. 1978 Jan;19(1):225–230. doi: 10.1128/iai.19.1.225-230.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Olsen G. A., Kern E. R., Overall J. C., Jr Effect of treatment with exogenous interferon, polyriboinosinic-polyribocytidylic acid, or polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex on Herpesvirus hominis infections in mice. J Infect Dis. 1978 Apr;137(4):428–436. doi: 10.1093/infdis/137.4.428. [DOI] [PubMed] [Google Scholar]
  31. Rivière Y., Gresser I., Guillon J. C., Tovey M. G. Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice. Proc Natl Acad Sci U S A. 1977 May;74(5):2135–2139. doi: 10.1073/pnas.74.5.2135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. STINEBRING W. R., YOUNGNER J. S. PATTERNS OF INTERFERON APPEARANCE IN MICE INFECTED WITH BACTERIA OR BACTERIAL ENDOTOXIN. Nature. 1964 Nov 14;204:712–712. doi: 10.1038/204712a0. [DOI] [PubMed] [Google Scholar]
  33. Schalla W. O., Johnson W. Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes. Infect Immun. 1975 Jun;11(6):1195–1202. doi: 10.1128/iai.11.6.1195-1202.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schiller J. G., Ribovich R., Feingold D. S., Youngner J. S. Interferon production in mice by components of Salmonella minnesota R595 lipid A. Infect Immun. 1976 Aug;14(2):586–589. doi: 10.1128/iai.14.2.586-589.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Shayegani M., Lief F. S., Mudd S. Specific and nonspecific cell-mediated resistance to influenza virus in mice. Infect Immun. 1974 Jun;9(6):991–998. doi: 10.1128/iai.9.6.991-998.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Stebbing N., Dawson K. M., Lindley I. J. Requirement for macrophages for interferon to be effective against encephalomyocarditis virus infection of mice. Infect Immun. 1978 Jan;19(1):5–11. doi: 10.1128/iai.19.1.5-11.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Tewari R. P., Lynn M., Birnbaum A. J., Solotorovsky M. Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae. Infect Immun. 1978 Jan;19(1):58–65. doi: 10.1128/iai.19.1.58-65.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. VILCEK J., TOMISOVA J., SOKOL F., HANA L. CONCENTRATION AND PARTIAL PURIFICATION OF INTERFERON FROM MOUSE BRAINS. Acta Virol. 1964 Jan;8:76–79. [PubMed] [Google Scholar]
  39. Youngner J. S., Feingold D. S., Chen J. K. Involvement of a chemical moiety of bacterial lipopolysaccharide in production of interferon in animals. J Infect Dis. 1973 Jul;128(Suppl):227–231. doi: 10.1093/infdis/128.supplement_1.s227. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES